Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.3.2.3 (
glutathione synthetase
)
678
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The pathogenesis of
Listeria monocytogenes
depends on the ability of this bacterium to escape from the phagosome of the host cells via the action of the pore-forming toxin listeriolysin O (LLO). Expression of the LLO-encoding gene (
hly
) requires the
transcriptional activator
PrfA, and both
hly
and
prfA
genes are essential for
L. monocytogenes
virulence. Here, we used the hemolytic activity of LLO as a phenotypic marker to screen for spontaneous virulence-attenuating mutations in
L. monocytogenes
Sixty nonhemolytic isolates were identified among a collection of 57,820 confirmed
L. monocytogenes
strains isolated from a variety of sources (0.1%). In most cases (56/60; 93.3%), the nonhemolytic phenotype resulted from nonsense, missense, or frameshift mutations in
prfA
Five strains carried
hly
mutations leading to a single amino acid substitution (G299V) or a premature stop codon causing strong virulence attenuation in mice. In one strain, both
hly
and
gshF
(encoding a
glutathione synthase
required for full PrfA activity) were missing due to genomic rearrangements likely caused by a transposable element. The PrfA/LLO loss-of-function (PrfA
-
/LLO
-
) mutants belonged to phylogenetically diverse clades of
L. monocytogenes
, and most were identified among nonclinical strains (57/60). Consistent with the rare occurrence of loss-of-virulence mutations, we show that
prfA
and
hly
are under purifying selection. Although occurring at a low frequency, PrfA
-
/LLO
-
mutational events in
L. monocytogenes
lead to niche restriction and open an evolutionary path for obligate saprophytism in this facultative intracellular pathogen.
...
PMID:Spontaneous Loss of Virulence in Natural Populations of Listeria monocytogenes. 2882 66